U.S. market Closed. Opens in 11 hours 54 minutes

ATNM | Actinium Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Revenue81.00K1.03M1.14MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue790.00K699.00K524.00K447.00K420.09KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-709.00K331.00K620.00K-447.00K-420.09KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses51.21M35.13M26.11M22.39M22.07M23.83M26.91M26.85M24.83M22.48M6.59M7.95M9.62K25.41K14.54KN/A11.99KN/A
Selling, General & Admin13.33M12.00M8.08M6.31M5.52M6.73M9.16M9.27M11.46M10.18M3.92M4.51M9.62K25.41K14.54K18.92K11.01K17.53K
Research & Development37.88M23.14M18.03M16.09M16.55M17.09M17.70M17.50M13.31M12.27M2.67M3.44MN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/AN/AN/AN/AN/AN/A55.94K77.52K53.47K37.91K1.56K581.00N/AN/AN/AN/A982.00N/A
Operating Income-51.92M-34.10M-24.96M-22.39M-22.07M-23.83M-26.91M-26.85M-24.83M-22.48M-6.59M-7.95M-9.62K-25.41K-14.54K-26.42K-11.99K-17.53K
Other Expenses / Income3.10M1.09M190.00K178.00K172.39K173.36K309.55K2.53M3.80M-2.21M-4.19M-413.91K19.90K27.08K-7.80KN/AN/AN/A
Before Tax Income-48.82M-33.02M-24.77M-22.21M-21.90M-23.65M-26.60M-24.32M-21.03M-24.69M-10.77M-8.36M10.29K1.67K-22.33KN/AN/AN/A
Income Tax Expenses622.11K-1.09M-190.00K-178.00K-172.39K173.36KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-48.82M-31.93M-24.58M-22.04M-21.73M-23.65M-26.60M-24.32M-21.03M-24.69M-10.77M-8.36M10.29K1.67K-22.33K-31.24K-14.80K-18.40K
Interest ExpensesN/A-1.09MN/AN/AN/A173.36KN/A5.01K7.87K866.002.51K1.10M4.76K6.62K6.40K4.82K2.81K870.00
Basic Shares Outstanding26.60M24.14M20.57M12.13M4.98M3.53M2.22M1.62M1.27M912.12K758.42K36.78K371.83K371.83K371.83K371.83K76.99K76.99K
Diluted Shares Outstanding26.60M24.14M20.57M12.13M4.98M3.53M2.22M1.62M1.27M912.12K758.42K36.78K371.83K371.83K371.83K371.83K76.99K76.99K
EBITDA-51.13M-33.41M-24.44M-21.95M-21.65M-23.78M-26.55M-26.77M-24.78M-22.44M-6.59M-7.95M-9.62K-25.41K-14.54K-26.42K-11.99K-17.53K
EBITDA Margin-63,123.46%-3,243.20%-2,136.36%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-48.20M-34.10M-24.77M-22.21M-21.90M-23.31M-26.60M-24.32M-21.02M-24.69M-10.77M-7.26M15.05K8.29K-15.93K-26.42K-11.99K-17.53K
EBIT Margin-59,501.10%-3,311.07%-2,165.56%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙